Question 1

How many shares of KNSA does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of KNSA (Kiniksa Pharmaceuticals Interna) before exiting the position in 2023-Q2.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's KNSA position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's KNSA position was last reported at $0 in 2023-Q2 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling KNSA?

Accepted Answer

In 2023-Q2, JACOBS LEVY EQUITY MANAGEMENT, INC exited their KNSA position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy KNSA?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in KNSA in 2019-Q4. They have held the position across 12 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2023-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$14.35	0
2023-Q1	Decreased	293,500	-9.3%	$3.2M	0.0%	$10.70	0
2022-Q4	Increased	323,737	+2.0%	$4.8M	0.0%	$14.98	27
2022-Q3	New	317,446	-	$4.1M	0.0%	$11.96	37
2021-Q3	Exited	0	-100.0%	$0	0.0%	$11.39	0
2021-Q2	Decreased	47,178	-6.6%	$657,000	0.0%	$14.33	0
2021-Q1	Increased	50,513	+28.2%	$935,000	0.0%	$18.09	31
2020-Q4	Decreased	39,394	-5.7%	$696,000	0.0%	$17.56	0
2020-Q3	Decreased	41,780	-7.5%	$640,000	0.0%	$15.55	0
2020-Q2	Decreased	45,157	-8.8%	$1.2M	0.0%	$26.00	0
2020-Q1	Decreased	49,524	-14.1%	$767,000	0.0%	$12.22	0
2019-Q4	New	57,627	-	$637,000	0.0%	$11.00	34

KNSA12 quarters

KNSA
12 quarters